-
Subject Areas on Research
-
'Signet-ring' cell gastric adenocarcinoma metastatic to a neurogenous hyperplasia of the appendix.
-
A Functional Polymorphism (rs2494752) in the AKT1 Promoter Region and Gastric Adenocarcinoma Risk in an Eastern Chinese Population.
-
A Predictive Model of Noncardia Gastric Adenocarcinoma Risk Using Antibody Response to Helicobacter pylori Proteins and Pepsinogen.
-
A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
-
A Review of Sleeve Gastrectomy Specimen Histopathology.
-
A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer.
-
A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer.
-
A Summary of the 2020 Gastric Cancer Summit at Stanford University.
-
A cohort analysis of U.S. stomach cancer mortality 1950-1977.
-
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.
-
A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer.
-
A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.
-
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
-
A pilot study of preoperative chemoradiation for gastric cancer.
-
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.
-
A stochastic compartment model of stomach cancer with correlated waiting time distributions.
-
ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
-
AGA Institute Quality Measure Development for the Management of Gastric Intestinal Metaplasia With Helicobacter pylori.
-
ASO Visual Abstract: Patterns and Impact of Fragmented Care in Stages II and III Gastric Cancer.
-
Abundant copy-number loss of CYCLOPS and STOP genes in gastric adenocarcinoma.
-
Acceptance of repeat esophagogastroduodenoscopy to detect gastric cancer in a Chinese immigrant cohort.
-
Adenocarcinoma of the stomach. Changing patterns over the last 4 decades.
-
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).
-
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
-
Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site.
-
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States.
-
An improved method for bivariate meta-analysis when within-study correlations are unknown.
-
An integrative approach identified genes associated with drug response in gastric cancer.
-
An unexpected intraoperative finding.
-
Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression.
-
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
-
Assessment of advanced gastric cancer management in the United States.
-
Assessment of spatial variation of risks in small populations.
-
Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck.
-
Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults.
-
Association of Helicobacter pylori and Autoimmune Gastritis With Stomach Cancer in a Cohort of Young Finnish Women.
-
Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in Hawaii.
-
Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population.
-
Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population.
-
Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study.
-
Benign gastric ulcer masquerading as a submucosal tumor.
-
CD44-SLC1A2 gene fusions in gastric cancer.
-
CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables.
-
Cancer Progress and Priorities: Gastric Cancer.
-
Carcinoids associated with multiple endocrine neoplasia syndromes.
-
Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids.
-
Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling.
-
Changing trends in the proportions of small (≤ 2 cm) proximal and non-proximal gastric carcinomas treated at a high-volume tertiary medical center in China.
-
Cimetidine and gastric carcinoma.
-
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
-
Circulating cytokines and gastric cancer risk.
-
Clinical and therapeutic relevance of PIM1 kinase in gastric cancer.
-
Clinico-pathologic conference: 12-year-old girl with fatigue, anemia, weight loss, abdominal distention, and occasional nausea and vomiting.
-
Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification.
-
Comment on "Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment".
-
Common and Co-Occurring Symptoms Experienced by Patients With Gastric Cancer.
-
Compartment model approach to the estimation of tumor incidence and growth: investigation of a model of cancer latency.
-
Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines.
-
Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.
-
Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes.
-
Comprehensive molecular characterization of gastric adenocarcinoma.
-
Computed tomography for staging esophageal and gastroesophageal cancer: reevaluation.
-
Computed tomography of the gastroesophageal junction: value of the left lateral decubitus view.
-
Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients.
-
Contribution of chemotherapy to improved prognosis in stage 4 gastric cancer: trend analysis of a regional population-based cancer registry in Japan.
-
Controlling Gastric Cancer in a World of Heterogeneous Risk.
-
Data Set for Reporting Carcinoma of the Stomach in Gastrectomy.
-
Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting.
-
Deep learning-based AI model for signet-ring cell carcinoma diagnosis and chemotherapy response prediction in gastric cancer.
-
Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system.
-
Defining surgical indications for type I gastric carcinoid tumor.
-
Development, validation, and evaluation of a risk assessment tool for personalized screening of gastric cancer in Chinese populations.
-
Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity.
-
Diabetic biomarkers and the risk of proximal or distal gastric cancer.
-
Diagnostic challenges of intra-operative frozen consultation for gastrointestinal signet ring cell carcinoma†.
-
Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men.
-
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials.
-
Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study.
-
Does the interval of screening endoscopy affect survival in gastric cancer patients?: A cross-sectional study.
-
E-cadherin in gastric carcinomas: Relations with histological parameters and its prognostic value.
-
EGFR Amplification as a Target in Gastroesophageal Adenocarcinoma: Do Anti-EGFR Therapies Deserve a Second Chance?
-
ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.
-
ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
-
Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis.
-
Endogenous glucocorticoids prevent gastric metaplasia by suppressing spontaneous inflammation.
-
Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.
-
Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma.
-
Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.
-
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.
-
Esophageal and esophagogastric junction cancers, version 1.2015.
-
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
-
Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas.
-
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
-
FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.
-
Familial aggregation of melanoma, basal cell carcinoma, and gastric adenocarcinoma.
-
Feeding jejunostomy tube placement during resection of gastric cancers.
-
First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
-
Flow cytometry as a predictive indicator in patients with operable gastric cancer.
-
Foregut carcinoids: a clinical and biochemical analysis.
-
Fruit and vegetable consumption and risk of distal gastric cancer in the Shanghai Women's and Men's Health studies.
-
Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: A pooled analysis of prospective studies in China, Japan, and Korea.
-
Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression.
-
Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients.
-
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
-
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.
-
Gastric adenocarcinoma associated with gastritis cystica profunda in an unoperated stomach.
-
Gastric adenocarcinoma: CT versus surgical staging.
-
Gastric cancer pharmacogenetics: progress or old tripe?
-
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.
-
Gastric cancer-molecular and clinical dimensions.
-
Gastric cancer.
-
Gastric cancer. Clinical practice guidelines in oncology.
-
Gastric cancer: an infectious disease.
-
Gastric carcinoma after gastrojejunostomy for benign disease: radiographic findings.
-
Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting.
-
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
-
Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation.
-
Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment: 177Lu-DOTATATE.
-
Gastrointestinal stromal tumors (GISTs) arising in uncommon locations: clinicopathologic features and risk assessment of esophageal, colonic, and appendiceal GISTs.
-
Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library.
-
Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing.
-
Genetic polymorphisms in the microRNA binding-sites of the thymidylate synthase gene predict risk and survival in gastric cancer.
-
Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese population.
-
Genetic variant rs4072037 of MUC1 and gastric cancer risk in an Eastern Chinese population.
-
Genetic variations in the mTOR gene contribute toward gastric adenocarcinoma susceptibility in an Eastern Chinese population.
-
Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population.
-
Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer.
-
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.
-
Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.
-
Helicobacter pylori Blood Biomarkers and Gastric Cancer Survival in China.
-
Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
-
Helicobacter pylori prevalence and circulating micronutrient levels in a low-income United States population.
-
Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation.
-
High rates of advanced gastric cancer in community of Flushing, New York.
-
Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation.
-
Histologic observations and P-glycoprotein expression in gastric and esophageal adenocarcinomas treated with preoperative chemotherapy.
-
Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic Role.
-
Hospital-level compliance with the commission on cancer's quality of care measures and the association with patient survival.
-
How do global trends in Helicobacter pylori prevalence inform prevention planning?
-
Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas.
-
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.
-
Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens.
-
Identification and functional characterization of JWA polymorphisms and their association with risk of gastric cancer and esophageal squamous cell carcinoma in a Chinese population.
-
Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
-
Immunostimulatory membrane proteins potentiate H. pylori-induced carcinogenesis by enabling CagA translocation.
-
Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma.
-
Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.
-
Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy.
-
Improved antitumor activity of a recombinant anti-Lewis(y) immunotoxin not requiring proteolytic activation.
-
Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene.
-
Intake of specific nonfermented soy foods may be inversely associated with risk of distal gastric cancer in a Chinese population.
-
Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
-
Integrated genomic characterization of oesophageal carcinoma.
-
Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma.
-
Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.
-
Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population.
-
Internal hernia after gastrectomy for cancer with Roux-Y reconstruction.
-
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.
-
Is there a dose-dependent effect of genetic susceptibility loci for gastric cancer on prognosis of the patients?
-
Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.
-
Laparoscopic Total Gastrectomy in the Western Patient Population: Tips, Techniques, and Evidence-based Practice.
-
Laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer: a systematic review.
-
Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study.
-
Leiomyoma involving the gastrocolic ligament: CT demonstration.
-
Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach.
-
Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer.
-
MDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population.
-
Malignant gastric outlet obstruction: bridging another divide.
-
Mantle zone lymphoma in a gastric glomus tumor.
-
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
-
Medication-Naïve Blood Pressure and Incident Cancers: Analysis of 2 Nationwide Population-Based Databases.
-
Methylation subtypes and large-scale epigenetic alterations in gastric cancer.
-
Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China.
-
Minimally invasive gastrectomy for gastric cancer: A national perspective on oncologic outcomes and overall survival.
-
Minimizing operative time for robotic gastrectomy in cancer: analysis of the major factors for four detailed steps.
-
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.
-
Nanoscale chromatin profiling of gastric adenocarcinoma reveals cancer-associated cryptic promoters and somatically acquired regulatory elements.
-
Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery.
-
Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk.
-
Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.
-
No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database.
-
Nomogram to predict lymph node metastasis in patients with early gastric cancer: a useful clinical tool to reduce gastrectomy after endoscopic resection.
-
Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study.
-
Oncogenic pathway combinations predict clinical prognosis in gastric cancer.
-
P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population.
-
PET/Computed Tomography and Precision Medicine: Gastric Cancer.
-
PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population.
-
Paradoxical relationship between chromosomal instability and survival outcome in cancer.
-
Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma.
-
Patterns and Impact of Fragmented Care in Stage II and III Gastric Cancer.
-
Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.
-
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.
-
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).
-
Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98).
-
Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.
-
Phase II study of 4'-deoxydoxorubicin (esorubicin) in advanced or metastatic adenocarcinoma of the stomach.
-
Phase II study of adriamycin with sequential methotrexate and 5-fluorouracil (AMF) in gastric carcinoma.
-
Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma.
-
Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study.
-
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients.
-
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.
-
Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
-
Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
-
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
-
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.
-
Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.
-
Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.
-
Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations.
-
Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study.
-
Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population.
-
Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer.
-
Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population.
-
Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis.
-
Population-based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women.
-
Potentially functional polymorphisms in the CASP7 gene contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population.
-
Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
-
Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population.
-
Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.
-
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with 131I-MIBG.
-
Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).
-
Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
-
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.
-
Preoperative chemoradiotherapy for locally advanced gastric cancer.
-
Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?
-
Prevalence of deleterious ATM germline mutations in gastric cancer patients.
-
Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial.
-
Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer.
-
Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
-
Race, African ancestry, and Helicobacter pylori infection in a low-income United States population.
-
Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract.
-
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).
-
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.
-
Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
-
Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development.
-
Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.
-
Results of radiation therapy in gastric cancer.
-
Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma.
-
Rt-PCR increases detection of submicroscopic peritoneal metastases in gastric cancer and has prognostic significance.
-
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach.
-
STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation.
-
Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
-
Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma.
-
Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers.
-
Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population.
-
Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data.
-
Simultaneous detection of the tumor suppressor FHIT gene and protein using the multi-functional biochip.
-
Smoking, Helicobacter Pylori Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and Korea.
-
Solid tumor second primary neoplasms: who is at risk, what can we do?
-
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.
-
Spatial and Temporal Heterogeneity of PD-L1 Expression and Tumor Mutational Burden in Gastroesophageal Adenocarcinoma at Baseline Diagnosis and after Chemotherapy.
-
Specific Histopathologic Features Aid in Distinguishing Diffuse-type Gastric Adenocarcinoma From Metastatic Lobular Breast Carcinoma.
-
Sporadic gastric carcinoid tumor laparoscopically resected: a case report.
-
Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis.
-
Subacute headache in a patient with metastatic gastric cancer.
-
Submucosal resection of giant gastric lipoma.
-
Symptom experience and self-management for multiple co-occurring symptoms in patients with gastric cancer: A qualitative study.
-
Synchronous resection of esophageal cancer and other organ malignancies: A systematic review.
-
Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers.
-
Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma.
-
TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract.
-
TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
-
Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer.
-
Technical considerations in radiation therapy for gastroesophageal junction cancer.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases.
-
The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases.
-
The Durham Initiative for Stomach Health (DISH): a pilot community-based Helicobacter pylori education and screening study.
-
The Prognostic Value of CD44 Expression in Epithelial-Mesenchymal Transition: Preliminary Data from Patients with Gastric and Esophageal Cancer.
-
The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis.
-
The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies.
-
The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer.
-
The association between gestational diabetes mellitus and cancer in women: A systematic review and meta-analysis of observational studies.
-
The association of cigarette smoking with gastric cancer: the multiethnic cohort study.
-
The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.
-
The expression of Claudin-4 in gastric cancer tissue: A single center experience.
-
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
-
The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer.
-
The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17.
-
The use of mortality time series data to produce hypothetical morbidity distributions and projects mortality trends.
-
Towards a tailored lymphadenectomy for gastric cancer based on the correlation between the primary tumor location and the first lymphatic drain basin: Preliminary data.
-
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
-
Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma.
-
Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.
-
Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach.
-
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer.
-
Whole-genome reconstruction and mutational signatures in gastric cancer.
-
Wnt proteins synergize to activate β-catenin signaling.
-
[Diagnosis of early gastric marginal zone lymphoma (MALT lymphoma) in endoscopic biopsies. Report of a case that demonstrates the utility of immunohistochemistry and the molecular analysis.].
-
[Variation of mortality risk among cancer patients and individualized therapy].
-
Keywords of People